Bcworld Pharm Co Stock Fundamentals
| 200780 Stock | KRW 4,800 10.00 0.21% |
BCWORLD PHARM Co fundamentals help investors to digest information that contributes to BCWORLD PHARM's financial success or failures. It also enables traders to predict the movement of BCWORLD Stock. The fundamental analysis module provides a way to measure BCWORLD PHARM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BCWORLD PHARM stock.
BCWORLD |
BCWORLD PHARM Co Company Current Valuation Analysis
BCWORLD PHARM's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BCWORLD PHARM Current Valuation | 232.12 B |
Most of BCWORLD PHARM's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BCWORLD PHARM Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BCWORLD PHARM Co has a Current Valuation of 232.12 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
BCWORLD PHARM Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BCWORLD PHARM's current stock value. Our valuation model uses many indicators to compare BCWORLD PHARM value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BCWORLD PHARM competition to find correlations between indicators driving BCWORLD PHARM's intrinsic value. More Info.BCWORLD PHARM Co is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about 0.03 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BCWORLD PHARM Co is roughly 31.70 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BCWORLD PHARM by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BCWORLD PHARM's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BCWORLD Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BCWORLD PHARM's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BCWORLD PHARM could also be used in its relative valuation, which is a method of valuing BCWORLD PHARM by comparing valuation metrics of similar companies.BCWORLD PHARM is currently under evaluation in current valuation category among its peers.
BCWORLD Fundamentals
| Return On Equity | 0.35 | |||
| Return On Asset | 0.011 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 232.12 B | |||
| Shares Outstanding | 7.69 M | |||
| Shares Owned By Insiders | 38.99 % | |||
| Shares Owned By Institutions | 0.70 % | |||
| Price To Sales | 2.09 X | |||
| Revenue | 61.62 B | |||
| Gross Profit | 23.61 B | |||
| EBITDA | 8.08 B | |||
| Net Income | 3.02 B | |||
| Cash And Equivalents | 2.75 B | |||
| Total Debt | 43.82 B | |||
| Cash Flow From Operations | (5.08 M) | |||
| Number Of Employees | 293 | |||
| Beta | 0.0185 | |||
| Market Capitalization | 59.99 B | |||
| Total Asset | 185.1 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0 % | |||
| Net Asset | 185.1 B |
About BCWORLD PHARM Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BCWORLD PHARM Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BCWORLD PHARM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BCWORLD PHARM Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BCWORLD PHARM
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BCWORLD PHARM position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BCWORLD PHARM will appreciate offsetting losses from the drop in the long position's value.Moving together with BCWORLD Stock
Moving against BCWORLD Stock
| 0.76 | 032640 | LG Uplus | PairCorr |
| 0.72 | 041510 | SM Entertainment | PairCorr |
| 0.71 | 122870 | YG Entertainment | PairCorr |
| 0.59 | 065660 | AnterogenCoLtd | PairCorr |
| 0.58 | 011390 | Busan Industrial | PairCorr |
The ability to find closely correlated positions to BCWORLD PHARM could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BCWORLD PHARM when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BCWORLD PHARM - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BCWORLD PHARM Co to buy it.
The correlation of BCWORLD PHARM is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BCWORLD PHARM moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BCWORLD PHARM moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BCWORLD PHARM can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in BCWORLD Stock
BCWORLD PHARM financial ratios help investors to determine whether BCWORLD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BCWORLD with respect to the benefits of owning BCWORLD PHARM security.